Avience BiomedicalsNSE:AVIENCE 5 Quick Ratio is 0.91 as of Jan. 2026. GuruFocus rates NSE:AVIENCE with a GF Score™ of 5/100. Among 854 Medical Devices & Instruments companies, Avience Biomedicals ranks worse than 117095.9% on this metric.
Avience Biomedicals has a quick ratio of 0.91. It indicates that the company cannot currently fully pay back its current liabilities.
The historical rank and industry rank for Avience Biomedicals's Quick Ratio or its related term are showing as below:
NSE:AVIENCE's Quick Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.865 * Ranked among companies with meaningful Quick Ratio only.
Avience Biomedicals (NSE:AVIENCE) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Avience Biomedicals Quick Ratio Related Terms
Avience Biomedicals Quick Ratio Historical Data
* Premium members only.
The historical data trend for Avience Biomedicals's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avience Biomedicals Quick Ratio Chart
Avience Biomedicals Annual Data
Trend
Mar23
Mar24
Mar25
Quick Ratio
0.58
0.51
1.03
Avience Biomedicals Quarterly Data
Mar23
Mar24
Mar25
Jan26
Quick Ratio
0.58
0.51
1.03
0.91
NSE:AVIENCE vs ABT, SYK, MDT: Quick Ratio Comparison
For the Medical Devices subindustry, Avience Biomedicals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avience Biomedicals Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avience Biomedicals's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Avience Biomedicals's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Avience Biomedicals's Quick Ratio for the fiscal year that ended in Mar. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avience Biomedicals (NSE:AVIENCE) has a Quick Ratio of 0.91 as of Jan. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Avience Biomedicals and its competitors. According to the industry distribution chart, Avience Biomedicals ranks #999999 out of 854 companies in the Medical Devices & Instruments industry.
Is Avience Biomedicals' Quick Ratio too high?
Avience Biomedicals' current Quick Ratio is 0.91. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Avience Biomedicals' value of 0.91 is 51.2% below this industry median. Based on the distribution chart, Avience Biomedicals ranks #999999 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Avience Biomedicals has a GF Score™ of 5/100, reflecting its overall financial health beyond just this single metric.
How does Avience Biomedicals' Quick Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Avience Biomedicals ranks #999999 out of 854 companies for Quick Ratio. This places Avience Biomedicals in the lower half of its industry. The industry median Quick Ratio is 1.87. Avience Biomedicals' value of 0.91 is 51.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avience Biomedicals's current Quick Ratio of 0.91 is 51.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Avience Biomedicals and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avience Biomedicals's current Quick Ratio is 0.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avience Biomedicals stock overvalued right now?
Avience Biomedicals (NSE:AVIENCE) has a current Quick Ratio of 0.91. The current Quick Ratio is 0.91 and 51.2% below the Medical Devices & Instruments industry median of 1.87. Avience Biomedicals' overall GF Score™ is 5/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Avience Biomedicals (NSE:AVIENCE), the current Quick Ratio is 0.91 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Avience Biomedicals Ltd is a medical consumables company focused on the manufacturing of Vitro-Diagnostic (IVD) products and medical devices. Its product offerings include diagnostic solutions used for the detection of diseases, conditions, and infections across laboratory, healthcare, and home-use applications. The company operates in areas including molecular biotechnology, genomics, and diagnostic products, and also provides distribution services for medical technology products in India. Its revenue is generated from Manufactured Goods and Traded Goods and Services, which include the sale of Medical Devices and Consumables.
5GF Score
Get the complete analysis for NSE:AVIENCE
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AVIENCE has been successfully added to your 